Vaccines Market Projected to Rise Lucratively During 2024: Top Players: AstraZeneca, Abbott, Bristol-Myers Squibb, Merck

Vaccines Market is Determined to cross a value of $65 Bn by 2024

Logo

Sellbyville, DE -- (SBWire) -- 05/21/2019 --Global Vaccines Market is set to exceed USD 70 billion by 2025; according to a new research report by Global Market Insights, Inc. Introduction of innovative technologies in vaccination, rising government support for product development will stimulate global vaccines market growth over the coming years. Growing awareness towards preventive vaccination in pediatric and increasing adoption of therapeutic vaccines in cancer treatment will fuel industry growth.

Increasing disease prevalence in underdeveloped countries coupled with growing incidence of cancer & HIV will serve as high impact rendering factor for the business growth. High cost and inadequate reimbursement coverage for vaccines will hamper industry expansion. Moreover, stringent government regulations for product approval will further restrain business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2186

Pediatric segment will witness 9.1% CAGR during the forecast timeframe owing to CDC recommendation for immunization schedule to protect children and infants before getting exposed to potentially life-threatening diseases. Attenuated vaccines technology segment accounted for more than 20% market share in 2018 and is estimated to grow significantly over the coming years due to factors such as robust antibody and cellular responses, and frequently deliberate lifelong immunity with only one or two doses.

Influenza disease segment will witness considerable growth to reach USD 6.1 billion by 2025 due to growing incidence, mounting number of disease-causing microbes (pathogens) and rising awareness in emerging economies towards disease prevention. Availability of vaccines at affordable prices in hospitals and clinics will augment the segment growth.

U.S. market dominated industry in 2018 by accounting for over 35% market share of global market owing to enormous impact of immunization on improving health of children and protecting them with vaccines due to epidemics of preventable diseases like mumps, pertussis, and measles. India will witness 13.4% CAGR during the forecast period due to improved efficiency of immunization programs and technological advancements in vaccine storage and transport. Rising per capita income, improved healthcare infrastructure and growing healthcare expenditure will promote business growth.

China market will grow at a substantial rate owing to rising disposable income, rapid economic growth, rising number of unvaccinated migrant workers, and delivery of efficient healthcare services. Brazil vaccines market will grow due to availability of vaccines at low cost and rising initiatives by Brazilian government to improve vaccination coverage will stimulate steady business expansion.

Vaccines Market, By Technology (USD Million)

1 Attenuated
2 Toxoid
3 Conjugate
4 Inactivated & subunit
5 Recombinant

Vaccines Market, By Disease (USD Million)

1 Cancer
2 Hepatitis
3 Pneumococcal disease
4 DTP
5 Dengue
6 Influenza
7 Human papilloma virus
8 Meningococcal disease
9 Polio
10 Rotavirus

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2186

Chapter 1. Methodology

1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. Global vaccines industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Age group trends
2.1.3. Disease trends
2.1.4. Technology trends
2.1.5. Regional trends

Chapter 3. Vaccines Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces

3.3.1. Growth drivers
3.3.1.1. Increasing government funding for vaccine development
3.3.1.2. Increasing vaccines R&D in developed nations
3.3.1.3. Increasing disease prevalence in underdeveloped countries
3.3.1.4. Growing incidences of cancer & HIV in Asia Pacific

Chapter 7. Vaccines Market, By Region

7.2. North America

7.2.1. Market estimates and forecast, by country, 2014 – 2025
7.2.2. Market estimates and forecast, by age group, 2014 – 2025
7.2.3. Market estimates and forecast, by technology, 2014 – 2025
7.2.4. Market estimates and forecast, by disease, 2014 – 2025

7.3. Europe

7.3.1. Market estimates and forecast, by country, 2014 – 2025
7.3.2. Market estimates and forecast, by age group, 2014 – 2025
7.3.3. Market estimates and forecast, by technology, 2014 – 2025
7.3.4. Market estimates and forecast, by disease, 2014 – 2025

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/vaccines-market

Data Tables

TABLE 1 Vaccines industry 3600 synopsis, 2014 – 2025
TABLE 2 Global vaccines market, 2014 – 2018 (USD Million)
TABLE 3 Global vaccines market, 2019 – 2025 (USD Million)
TABLE 4 Global vaccines market, by age group, 2014 - 2018 (USD Million)
TABLE 5 Global vaccines market, by age group, 2019 - 2025 (USD Million)
TABLE 6 Global vaccines market, by technology, 2014 – 2018 (USD Million)
TABLE 7 Global vaccines market, by technology, 2019 – 2025 (USD Million)
TABLE 8 Global vaccines market, by disease, 2014 – 2018 (USD Million)
TABLE 9 Global vaccines market, by disease, 2019 – 2025 (USD Million)
TABLE 10 Global vaccines market, by region, 2014 – 2018 (USD Million)

Media Relations Contact

Arun Hegde
Corporate Sales
Global Market Insights, Inc.
1-888-689-0688
https://www.gminsights.com/industry-analysis/vaccines-market

View this press release online at: http://rwire.com/1220254